CPRX Catalyst Corp: Earnings per share for the last twelve months

Official company branding of Catalyst Corp (CPRX)

Catalyst Pharmaceuticals relies on outsourced manufacturing, depending on external suppliers. Exclusive rights to orphan drugs facilitate easy sales expansion with minimal costs, while environmental impact is limited to partner audits. The annual EPS growth based on financial reporting (TTM) illustrates the earnings per share trend, where the current metric equals 9.60.

Catalyst Pharmaceuticals, Inc. (CPRX): Earnings per share for the last twelve months from 02/11/2024 to 07/25/2026

Financial and market metric breakdowns for Catalyst Pharmaceuticals (CPRX)

- current quotes and average value forecast:
Stock Price Catalyst Pharma|CPRX - Price Target Chart
- company stock capitalization data:
Market Value Catalyst Pharmaceuticals|CPRX - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Net Asset Value per Share Catalyst Pharmaceuticals|CPRX - Company Book Value|Market Capitalization to Book Value catalystpharma.com|CPRX - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital Catalyst Pharmaceuticals|CPRX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital catalystpharma.com|CPRX - Company Debts|Debts to Book Capitalization Ratio Catalyst Pharmaceuticals Inc|CPRX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Catalyst Pharmaceuticals|Quick Ratio catalystpharma.com
- net income and valuation ratios data:
CPRX - Company Net Income|Expected Net Income Catalyst Pharmaceuticals|CPRX - Price to Earnings Ratio|Projected Price to Earnings Catalyst Pharmaceuticals Inc|CPRX - PEG Multiple|EV/EBITDA Multiple Catalyst Pharmaceuticals Inc|CPRX - Operating profit EBITDA|Net earnings per share for the last 12 months Catalyst Pharmaceuticals|CPRX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months catalystpharma.com|CPRX - Net earnings per share growth this year|Earnings growth forecast for next year Catalyst Pharmaceuticals
- revenue and sales details:
CPRX - Company Sales|Company Projected Revenue Volume Catalyst Pharmaceuticals, Inc.|CPRX - P/S Multiple|Market Cap to Expected Sales Ratio Catalyst Pharmaceuticals Inc
Initial company analysis:Catalyst Pharmaceuticals, Inc.
Manufactured products of Catalyst Corp

This indicator measures the dynamics of earnings per share over the last twelve months relative to the same period last year, reflecting the efficiency of capital generation. For Catalyst Pharmaceuticals (CPRX), the comparable year-over-year growth in EPS TTM confirms high business margins driven by exclusive rights to orphan drugs and a lack of competition in the rare disease segment.

Competitor analysis for Catalyst Pharmaceuticals

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE